Similarly, empagliflozin can mitigate inflammation and macrophage stimulation by downregulating JAK2/STAT1 pathway and optimize energy expenditure (Xu et al., 2019
Rosenthal, MD,FASMBS, a past president of the American Society of Metabolic & Bariatric Surgery (ASMBS), noting that bariatric surgery consults are down 30% nationwide in the past year
Conversely, indicators of responsible positioning include: honest acknowledgment that mechanisms differ from pharmaceutical drugs, realistic expectation-setting about gradual metabolic support rather than dramatic transformation, transparent disclosure of all strains and doses, quality manufacturing claims (GMP certification, third-party testing), and guarantee periods aligning with research assessment timelines
Pair flavors with complementary sweeteners (e.g., allulose, monk fruit) and masking agents to maintain consumer acceptance